Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

257 (7%)

Anticipated shortage:

3 (0%)

Avoided shortage:

11 (0%)

Resolved:

3300 (92%)

3571

Discontinuation Reports

To be discontinued:

24 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

366

143 (4%)

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2024-04-26 2024-06-14 226309
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2022-08-12 2023-01-13 166604
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2019-10-09 2019-11-04 95874
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2022-11-04 2022-12-09 173823
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2025-12-20 2026-01-03 274822
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2020-10-07 2020-12-29 125809
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2021-06-18 2021-07-26 141247
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2020-10-07 2021-01-26 125806
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2021-06-11 2021-07-26 140777
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2019-10-09 2019-11-04 95871
APO-NADOLOL 40MG TABLET Resolved 2025-10-10 2025-12-12 269344
APO-NADOLOL 40MG TABLET Resolved 2023-11-17 2024-01-26 210715
APO-NADOLOL 40MG TABLET Resolved 2022-09-30 2022-11-20 170801
APO-NADOLOL 80MG TABLET Resolved 2023-12-08 2024-01-26 212919
APO-NALTREXONE 50MG TABLET Resolved 2021-02-12 2021-03-15 133991
APO-NALTREXONE 50MG TABLET Resolved 2018-11-21 2019-02-01 67404
APO-NALTREXONE 50MG TABLET Resolved 2020-04-06 2020-05-04 111060
APO-NALTREXONE 50MG TABLET Resolved 2017-11-28 2018-01-16 31016
APO-NALTREXONE 50MG TABLET Resolved 2021-08-13 2021-08-31 144142
APO-NALTREXONE 50MG TABLET Resolved 2023-01-06 2023-03-30 180119
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-RILUZOLE 50MG TABLET To be discontinued 2018-09-08 2018-09-08 60744
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260